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Abstract
P-glycoprotein is a transmembrane protein which acts as an energy-dependent drug efflux
pump for a variety of anti-cancer drugs. The mdr-1 gene which encodes P-glycoprotein was suc-
cessfully cloned in 1986. To investigate P-glycoprotein expression in diverse ovarian tumors,
including benign, low malignant potential and malignant, immunohistochemical study was done
using a monoclonal antibody (C 219). Overall, 8 out of the 59 epithelial ovarian tumors (13.6%)
expressed P-glycoprotein. It was noted that 5 of the 12 mucinous tumors were found to express
P-glycoprotein, while none of the 31 serous tumors were immunohistochemically positive. In 10
malignant ovarian tumors, P-glycoprotein immunostaining was examined both prior to and after
chemotherapy. Nine of them did not express any P-glycoprotein before or after chemotherapy.
However, one tumor expressed P-glycoprotein after six courses of multidrug resistance-related
drug administration. These findings indicate that P-glycoprotein expression is not so common
in ovarian tumors, regardless of their malignant potential. Nevertheless, the results suggest a
strong association between P-glycoprotein expression and certain histological cell types in epithe-
lial ovarian tumors. It is also possible that P-glycoprotein appears as a result of chemotherapy, but
such a phenomenon can not occur unless chemotherapy is administered at high doses for a long
period of time.
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